Hepatic Immunomodulatory Effect of Belatacept on the TNF-?/IL-6 Pro-Inflammatory Axis and its Impact on Regulation of Mirna-146a in Hepatic Injury. (PubMed, Med Princ Pract) - Sep 12, 2026 - "These findings show that belatacept has stronger immunomodulatory action when compared with standard therapy. Belatacept is a promising new treatment option for liver-driven systemic inflammation which acts by inhibiting the TNF-α/IL-6 axis and modulating miRNA-146a."
Journal • Hepatology • Liver Failure • Oncology • IL6 • TNFA
|
|
Doaa Khalid Ibrahim; Huda Waheed; Yassir Mustafa Kamal Al Mulla Hummadi
|